{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:24:49Z","timestamp":1791854689564,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,10,13]],"date-time":"2003-10-13T00:00:00Z","timestamp":1066003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl J Eating Disorders"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Increased plasma levels of allopregnenolone (3\u03b1,5\u03b1\u2010tetrahydroprogesterone [3\u03b1,5\u03b1\u2010THP]), dehydroepiandrosterone (DHEA), and DHEA sulphate (DHEA\u2010S) have been reported in patients with anorexia nervosa or bulimia nervosa. To assess whether those changes are related to malnutrition, we investigated plasma levels of neuroactive steroids in women with binge eating disorder (BED) who compulsively binge as bulimic patients, but do not incur malnutrition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixty\u2010eight women participated in the study (31 nonobese healthy controls, 9 nonobese patients with BED, 16 obese patients with BED, and 12 obese non\u2010binge eating women). Blood samples were collected in the morning for determination of plasma levels of 3\u03b1,5\u03b1\u2010THP, DHEA, DHEA\u2010S, and cortisol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nonobese BED women had significantly higher plasma levels of DHEA, DHEA\u2010S, and 3\u03b1,5\u03b1\u2010THP than nonobese healthy women. Similarly, obese individuals with BED exhibited significantly higher neurosteroid plasma levels than non\u2010binge eating obese subjects. No significant differences in plasma cortisol levels were observed among the groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study shows increased plasma levels of neuroactive steroids in BED patients. These findings could have been influenced by methodologic limitations (e.g., the absence of diurnal sampling). However, they suggest that if malnutrition is involved in the determination of increased plasma levels of neuroactive steroids in people with anorexia or bulimia nervosa, then different factors may induce similar effects in people with BED. Alternatively, common unknown factors could be responsible for neurosteroid changes in anorexia nervosa, bulimia nervosa, and BED. \u00a9 2003 by Wiley Periodicals, Inc. Int J Eat Disord 34: 432\u2013440, 2003.<\/jats:p><\/jats:sec>","DOI":"10.1002\/eat.10199","type":"journal-article","created":{"date-parts":[[2003,10,15]],"date-time":"2003-10-15T16:53:40Z","timestamp":1066236820000},"page":"432-440","source":"Crossref","is-referenced-by-count":33,"title":["Circulating levels of neuroactive steroids in patients with binge eating disorder: A comparison with nonobese healthy controls and non\u2010binge eating obese subjects"],"prefix":"10.1002","volume":"34","author":[{"given":"Palmiero","family":"Monteleone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Luisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Colurcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,13]]},"reference":[{"key":"e_1_2_1_2_1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.9.8784058"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90761-J"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7244.1240"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.3.1026"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-3-564"},{"key":"e_1_2_1_8_1","volume-title":"BMDP statistical software","author":"Dixon J.","year":"1985"},{"key":"e_1_2_1_9_1","volume-title":"Structured Clinical Interview for DSM\u2010IV axis I disorders\u2010patient ed. (SCID\u2010I\/P, Version 2)","author":"First M.B.","year":"1995"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jcem.83.6.4905","article-title":"Circulating levels of allopregnanolone in humans: Gender, age, and endocrine influences","volume":"83","author":"Genazzani A.R.","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00692.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2422758"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-200101000-00008"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.3.549"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-5-1040"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-1-4-392"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(00)00286-9"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050635"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(99)01399-5"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.428"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/mend.12.9.0163"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.4.646"},{"key":"e_1_2_1_23_1","volume-title":"Obesity: Preventing and managing the global epidemic: Report of a WHO consultation on obesity (WHO\/NUT\/NCD\/98.1)","author":"World Health Organization","year":"1998"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201x.1999.00579.x"}],"container-title":["International Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Feat.10199","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/eat.10199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:09:12Z","timestamp":1700244552000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/eat.10199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,13]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1002\/eat.10199"],"URL":"https:\/\/doi.org\/10.1002\/eat.10199","archive":["Portico"],"relation":{},"ISSN":["0276-3478","1098-108X"],"issn-type":[{"value":"0276-3478","type":"print"},{"value":"1098-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,13]]}}}